A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. - Kao CM; Rostad CA; Nolan LE; Peters E; Kleinhenz J; Sherman JD; Tippett A; Shih JWK; Yildirim I; Agbakoba V; Beresnev T; Ballou C; et al. (The Journal of infectious diseases, 2024)